[Future directions in prophylaxis and treatment of venous thromboembolic disease].
Substantial changes in both the prevention and treatment of venous thromboembolism (VTE) can be expected in the near future. First, we should expand the prescription of thromboprophylaxis to acutely ill medical patients and improve the early detection of VTE in patients at high risk. The new antithrombotic drugs, which will shortly become available, will probably improve adherence to thromboprophylaxis. Future perspectives focus on better identification of which patients with acute pulmonary embolism may safely be treated at home, and on how to individually tailor antithrombotic therapy to VTE patients with special conditions.
Monreal
Manuel
M
Servicio de Medicina Interna, Hospital Germans Trias i Pujol, Badalona, Barcelona, España. mmonreal.germanstrias@gencat.cat
D000208:Acute Disease; D000284:Administration, Oral; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005544:Forecasting; D006470:Hemorrhage / Q000139:chemically induced / Q000401:mortality; D006699:Home Care Services; D006801:Humans; D007279:Injections, Subcutaneous; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D012449:Safety; D014463:Ultrasonography; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000517:prevention & control*
D005343:Fibrinolytic Agents